Shares of Lupin Ltd were trading flat on 9 May after the company announced securing approval from the United States Food and Drug Administration (USFDA)...
Following President Trump’s signing of an Executive Order to boost domestic drug production facilities, leading pharmaceutical exporters to the United States may risk commercial disruption,...
Shares of Lupin Ltd crashed 5% on 11 February despite the US Food and Drug Administration’s (USFDA) approval of the company’s nasal spray. The USFDA...
Shares of Lupin Ltd were trading in the green and 1% higher on 9 January despite the company’s Pithampur unit-1 manufacturing facility has received an...